Sana Biotechnology Announces Proposed Public Offering of Common Stock

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Nasdaq:SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock. In addition, Sana intends to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of shares of its common stock. All of the shares to be sold in this offering will be sold by Sana. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the proposed offering.

Read more at globenewswire.com